AAAAAA

   
Results: 1-15 |
Results: 15
Improved methods for determining the concentration of 6-thioguanine nucleotides and 6-methylmercaptopurine nucleotides in blood
Authors: Pike, MG Franklin, CL Mays, DC Lipsky, JJ Lowry, PW Sandborn, WJ
Citation: Mg. Pike et al., Improved methods for determining the concentration of 6-thioguanine nucleotides and 6-methylmercaptopurine nucleotides in blood, J CHROMAT B, 757(1), 2001, pp. 1-9
Metabolism of a disulfiram metabolite, S-methyl N,N-diethyldithiocarbamateby flavin monooxygenase in human renal microsomes
Authors: Pike, MG Mays, DC Macomber, DW Lipsky, JJ
Citation: Mg. Pike et al., Metabolism of a disulfiram metabolite, S-methyl N,N-diethyldithiocarbamateby flavin monooxygenase in human renal microsomes, DRUG META D, 29(2), 2001, pp. 127-132
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide
Authors: Lowry, PW Franklin, CL Weaver, AL Szumlanski, CL Mays, DC Loftus, EV Tremaine, WJ Lipsky, JJ Weinshilboum, RM Sandborn, WJ
Citation: Pw. Lowry et al., Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide, GUT, 49(5), 2001, pp. 656-664
Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease
Authors: Lowry, PW Franklin, CL Weaver, AL Pike, MG Mays, DC Tremaine, WJ Lipsky, JJ Sandborn, WJ
Citation: Pw. Lowry et al., Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease, GUT, 49(5), 2001, pp. 665-670
Determination of in vivo adducts of disulfiram with mitochondrial aldehydedehydrogenase
Authors: Shen, ML Johnson, KL Mays, DC Lipsky, JJ Naylor, S
Citation: Ml. Shen et al., Determination of in vivo adducts of disulfiram with mitochondrial aldehydedehydrogenase, BIOCH PHARM, 61(5), 2001, pp. 537-545
Thermal technologies for space suits
Authors: Mays, DC Campbell, AB Nair, SS Miles, JB Thomas, GA
Citation: Dc. Mays et al., Thermal technologies for space suits, ASHRAE J, 43(1), 2001, pp. 25
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: A case study of five patients with treatment-resistantinflammatory bowel disease
Authors: Egan, LJ Tremaine, WJ Mays, DC Lipsky, JJ Sandborn, WJ
Citation: Lj. Egan et al., Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: A case study of five patients with treatment-resistantinflammatory bowel disease, INFLAMM B D, 6(4), 2000, pp. 286-289
Identification of the protein-drug adduct formed between aldehyde dehydrogenase and S-methyl-N,N-diethylthiocarbamoyl sulfoxide by on-line proteolytic digestion high performance liquid chromatography electrospray ionization mass spectrometry
Authors: Shen, ML Johnson, KL Mays, DC Lipsky, JJ Naylor, S
Citation: Ml. Shen et al., Identification of the protein-drug adduct formed between aldehyde dehydrogenase and S-methyl-N,N-diethylthiocarbamoyl sulfoxide by on-line proteolytic digestion high performance liquid chromatography electrospray ionization mass spectrometry, RAP C MASS, 14(10), 2000, pp. 918-923
Intravenous azathioprine in severe ulcerative colitis: A pilot study
Authors: Mahadevan, U Tremaine, WJ Johnson, T Pike, MG Mays, DC Lipsky, JJ Sandborn, WJ
Citation: U. Mahadevan et al., Intravenous azathioprine in severe ulcerative colitis: A pilot study, AM J GASTRO, 95(12), 2000, pp. 3463-3468
Plasma and rectal adenosine in inflammatory bowel disease: Effect of methotrexate
Authors: Egan, LJ Sandborn, WJ Mays, DC Tremaine, WJ Lipsky, JJ
Citation: Lj. Egan et al., Plasma and rectal adenosine in inflammatory bowel disease: Effect of methotrexate, INFLAMM B D, 5(3), 1999, pp. 167-173
A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis
Authors: Egan, LJ Sandborn, WJ Tremaine, WJ Leighton, JA Mays, DC Pike, MG Zinsmeister, AR Lipsky, JJ
Citation: Lj. Egan et al., A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis, ALIM PHARM, 13(12), 1999, pp. 1597-1604
Roles of FMO and CYP450 in the metabolism in human liver microsomes of S-methyl-N,N-diethyldithiocarbamate, a disulfiram metabolite
Authors: Pike, MG Martin, YN Mays, DC Benson, LM Naylor, S Lipsky, JJ
Citation: Mg. Pike et al., Roles of FMO and CYP450 in the metabolism in human liver microsomes of S-methyl-N,N-diethyldithiocarbamate, a disulfiram metabolite, ALC CLIN EX, 23(7), 1999, pp. 1173-1179
Inhibition of interleukin-1-stimulated NF-kappa B RelA/p65 phosphorylationby mesalamine is accompanied by decreased transcriptional activity
Authors: Egan, LJ Mays, DC Huntoon, CJ Bell, MP Pike, MG Sandborn, WJ Lipsky, JJ McKean, DJ
Citation: Lj. Egan et al., Inhibition of interleukin-1-stimulated NF-kappa B RelA/p65 phosphorylationby mesalamine is accompanied by decreased transcriptional activity, J BIOL CHEM, 274(37), 1999, pp. 26448-26453
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease
Authors: Sandborn, WJ Tremaine, WJ Wolf, DC Targan, SR Sninsky, CA Sutherland, LR Hanauer, SB McDonald, JWD Feagan, BG Fedorak, RN Isaacs, KL Pike, MG Mays, DC Lipsky, JJ Gordon, S Kleoudis, CS Murdock, RH
Citation: Wj. Sandborn et al., Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease, GASTROENTY, 117(3), 1999, pp. 527-535
Systemic and intestinal pharmacokinetics of methotrexate in patients with inflammatory bowel disease
Authors: Egan, LJ Sandborn, WJ Mays, DC Tremaine, WJ Fauq, AH Lipsky, JJ
Citation: Lj. Egan et al., Systemic and intestinal pharmacokinetics of methotrexate in patients with inflammatory bowel disease, CLIN PHARM, 65(1), 1999, pp. 29-39
Risultati: 1-15 |